GENETESIS NEWSROOM

What's New With Genetesis

Stay up-to-date with the latest Genetesis headlines, including product updates, research announcements, and more.

Genetesis Receives 2nd FDA Breakthrough Device Designation for Non-Invasive Diagnosis of Myocardial Ischemia Using CardioFlux MCG

January 20, 2023

Genetesis Announces New Appointments to Executive Leadership Team

October 6, 2022

Genetesis Announces Close of $17.5 Million Series C Financing

recognized for our work

Our Awards & Recognition

2022 Forbes 30 Under 30 Recepient in Healthcare

2019 Cincy Inno's Coolest Companies

VentureOhio's 2017 Seed Stage Company of the Year & 2018 Early Stage Company

Nvidia Inception Award for Best AI Social Impact Startup

Media Coverage

November 29, 2022

Genetesis Founder Named Forbes 30 Under 30

October 6, 2020

Ms. Medicine and Genetesis Initiate WACE-MCG Clinical Registry

January 6, 2021

CardioFlux Magnetocardiograph Case Studies

January 31, 2021

Genetesis Applauds CMS’s MCIT Rule to Prove National Medicare Coverage For FDA Breakthrough Devices

COVID-19 Further Overwhelms Chest Pain Triage Inefficiencies

January 30, 2020

Magnetocardiography IDs Chest Pain in 90 Seconds

Media Kit

Couldn't find what you need? Reach out through our contact form.

Media Kit

Our current guidelines and brand photography including founder headshots and device photos.

Download Media Kit

Logo Download

Download the primary Genetesis logo or any of its varied colors and lockups.